Gregg Wallis
Overview
Explore the profile of Gregg Wallis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barnidge D, Troske D, North S, Wallis G, Perkins M, Harding S
J Mass Spectrom Adv Clin Lab
. 2024 Feb;
32:31-40.
PMID: 38405412
Introduction: The EXENT® Solution, a fully automated system, is a recent advancement for identifying and quantifying monoclonal immunoglobulins in serum. It combines immunoprecipitation with MALDI-TOF mass spectrometry. Compared to gel-based...
2.
Iles J, Zmuidinaite R, Sadee C, Gardiner A, Lacey J, Harding S, et al.
Int J Mol Sci
. 2022 Jun;
23(11).
PMID: 35682724
The involvement of immunoglobulin (Ig) G3 in the humoral immune response to SARS-CoV-2 infection has been implicated in the pathogenesis of acute respiratory distress syndrome (ARDS) in COVID-19. The exact...
3.
Tange C, Johnson-Brett B, Cook A, Stordeur P, Brohet F, Jolles S, et al.
Clin Chem Lab Med
. 2018 May;
56(9):1498-1506.
PMID: 29729138
Background: The measurement of complement components is clinically useful where a deficiency is suspected, or where excessive activation and consumption are present in disease. C2 deficiency carries an increased risk...
4.
Parker A, Irure Ventura J, Sims D, Echeverria de Carlos A, Gomez de la Torre R, Tricas Aizpun L, et al.
J Immunoassay Immunochem
. 2017 Jun;
38(5):514-522.
PMID: 28613137
IgG2 is the most efficient subclass for providing protection against pneumococcal pathogens. We hypothesised that some individuals may be unable to mount an effective pneumococcal capsular polysaccharide (PCP) IgG2 response...